Home › Funds › MFS Investment Management › BEAM
MFS Investment Management position in BEAM
BEAM THERAPEUTICS INC · Health Care
Latest position (Q2 2025)55.47K sh
Reported value held$943.46K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 19.35K | $922.00K | New |
| Q4 2022 | 20.91K | $817.67K | Add |
| Q1 2023 | 10.41K | $318.72K | Reduce |
| Q2 2024 | 59.09K | $1.38M | New |
| Q3 2024 | 57.70K | $1.41M | Reduce |
| Q4 2024 | 56.03K | $1.39M | Reduce |
| Q1 2025 | 54.78K | $1.07M | Reduce |
| Q2 2025 | 55.47K | $943.46K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BEAM
- Fidelity Management & Research (FMR) 12.61M sh · $432.74M · Q2 2026
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- BlackRock Inc 9.00M sh · $308.80M · Q2 2026
- Vanguard Group 9.19M sh · $254.84M · Q4 2025
- Geode Capital Management 2.60M sh · $89.14M · Q2 2026
- Morgan Stanley 1.95M sh · $66.96M · Q2 2026
- Two Sigma Investments 1.39M sh · $47.64M · Q2 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Goldman Sachs Group 1.31M sh · $44.96M · Q2 2026
- Northern Trust Corp 933.48K sh · $32.04M · Q2 2026
- Charles Schwab Investment Management 885.90K sh · $30.40M · Q2 2026